Immunohistochemistry (IHC) Market Share, Opportunities Analysis, Recent Trends, Regional Growth And Outlook By 2033

The immunohistochemistry (ihc) market size has grown strongly in recent years. It will grow from $2.43 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to clinical adoption, industry standardization, expansion in cancer research, automation in laboratories, clinical diagnostics advancements..

The immunohistochemistry (ihc) market size is expected to see strong growth in the next few years. It will grow to $3.77 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to market entry of new players, demand in drug development, biomedical research integration, diagnostic applications, automation and digitalization.. Major trends in the forecast period include multiplex ihc techniques, digital pathology integration, enhanced antibody specificity, automation and standardization, application in biomarker discovery..

Market Overview -
Immunohistochemistry (IHC) is the technique in diagnosis that uses antibody-antigen interaction to locate particular proteins and antigens in the tissue section. This interaction is visualized using chromogenic detection using enzyme-substrate or fluorescent detection using fluorescent dye.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

Increase In Chronic Diseases Prevalence Boosts Immunohistochemistry (IHC) Market Growth
The increase in the prevalence of chronic diseases is expected to propel the immunohistochemistry (IHC) market going forward. Chronic diseases refer to clinical conditions that last for three months or more extended periods and usually can be controlled but not cured. Immunohistochemistry helps in diagnosing chronic diseases such as cancer, cardiovascular disorders, and others due to its various advantages, such as its specificity, sensitivity (used to detect specific antigens), rapid results, and others. For instance, in 2022, according to the Centers for Disease Control and Prevention, a US-based national public health agency, around 37.3 million people have diabetes which equals 11.3% of the United States population. Therefore, an increase in the prevalence of chronic diseases is driving the growth of the immunohistochemistry (IHC) market.

Competitive Landscape -
Major companies operating in the immunohistochemistry (ihc) market report are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc. .

Technological Advancements Propel Innovation In Immunohistochemistry (IHC) Market
Technological advancement is the key trend in the immunohistochemistry (IHC) market. Major companies operating in the market are focused on developing technologically advanced products to strengthen their position in the market. For instance, in April 2021, Akoya Biosciences, Inc, a US-based company operating in end-to-end solutions for high-parameter tissue analysis, introduced its new multiplex detection kits based on Opal multiplex technology known as Akoya's Opal Multiplex Detection Kits. The opal multiplex technique is a methodology for detecting multiple biomarkers in one section of tissue that encompasses iterative single staining and heating-mediated removal of the primary stain. Akoya's Opal Multiplex Detection Kits provide phenotypic scoring using signal amplification, low sample and reagent consumption, can measure 3 to 8 IHC targets and nuclear stains, and other advanced features.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

Key Segments -
The immunohistochemistry (ihc) market covered in this report is segmented -
1) By Product: Antibodies, Equipment, Reagents, Kits
2) By Applications: Diagnostics, Drug Testing, Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.